EnGene posts more pivotal data for bladder cancer gene therapy, plans 2026 filingnews2025-11-11T12:30:20+00:00November 11th, 2025|Endpoints News|
#AHA25: CRISPR Therapeutics’ gene editing therapy halves cholesterol and triglycerides in early trialnews2025-11-10T15:25:01+00:00November 10th, 2025|Endpoints News|
Patient in Intellia CRISPR trial dies after being hospitalized with liver injurynews2025-11-07T02:34:55+00:00November 7th, 2025|Endpoints News|
Jennifer Doudna startup Azalea Therapeutics launches with $82Mnews2025-11-04T13:00:49+00:00November 4th, 2025|Endpoints News|
UniQure’s Huntington’s gene therapy is delayed, as FDA suggests it may walk back accelerated approval blessingnews2025-11-03T13:34:28+00:00November 3rd, 2025|Endpoints News|
Caribou says it’s cracked ‘off-the-shelf’ cell therapy, but needs to raise money to move forwardnews2025-11-03T12:00:16+00:00November 3rd, 2025|Endpoints News|
Baby KJ researchers publish FDA interactions as agency eyes new pathwaynews2025-10-31T19:14:34+00:00October 31st, 2025|Endpoints News|
Post-Hoc Live: Meet the scientists behind Baby KJ’s life-saving CRISPR therapynews2025-10-31T11:00:14+00:00October 31st, 2025|Endpoints News|
Gilead sees cell therapy sales decline in Q3news2025-10-31T01:45:15+00:00October 31st, 2025|Endpoints News|
Kyverna says small group of rare disease patients all responded to its CAR-Tnews2025-10-29T14:44:27+00:00October 29th, 2025|Endpoints News|
